Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

62 Results Found

AHA comments on CY 2026 OPPS proposed rule

The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical center payment system proposed rule.

Appeals court upholds lower court denial of AbbVie’s preliminary injunction, preserving Mississippi 340B contract pharmacy law

The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.

AHA urges FTC, DOJ to investigate anticompetitive activity by drug companies on 340B rebate models 

The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts to impose rebate models within the 340B Drug Pricing Program, saying the actions may violate antitrust laws.

AHA comments to HRSA on proposed 340B rebate model program

The AHA Aug. 27 said the Health Resources and Services Administration should abandon its 340B Rebate Model Pilot Program.

AHA, others urge HRSA to extend timeline for comments and feedback on 340B pilot program

The AHA, joined by several other national groups representing 340B hospitals, Aug. 8 urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.

AHA defends HHS decision to reject 340B rebate models by drug companies

The AHA today filed an amicus brief in the U.S.

HHS announces new 340B Rebate Model Pilot Program

The Department of Health and Human Services today issued a

AHA files brief defending Colorado’s 340B contract pharmacy law

The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.